Clinical Trial Update: A Study to Assess APO866 for the Treatment of Advanced Melanoma [Phase 2]

View source ↗

Summary

This update notes the completion of a Phase 2 study evaluating APO866 for advanced melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• APO866

Snippet

Sponsor: Valerio Therapeutics | Conditions: Melanoma | Phase 2 | Status: COMPLETED